BPC-157 vs Ibuprofen for pain & inflammation
Short answer: For pain & inflammation, more users report improvement with Ibuprofen — 96% of 25 reports, versus 86% of 485 for BPC-157.
BPC-157 has 0 meta-analyses and 0 randomized trials on PubMed; Ibuprofen has 511 and 1,743.
Based on 1,613 reports about BPC-157 and 83 about Ibuprofen. Not medical advice.
| BPC-157 Peptide | Ibuprofen Medication | |
|---|---|---|
| Users say it helped | 54%helped919 reports · high confidence | 62%helped50 reports · medium confidence |
| Verdict | Mixed | Mostly positive |
| Research | DResearch: None | AResearch: Strong |
| Meta-analyses / RCTs | 0 / 0 | 511 / 1,743 |
| Mainly used for | ||
| Pain & inflammation % reporting improvement | 86% (485) | 96% (25) |
| Recovery % reporting improvement | 96% (494) | 33% (3) |
| Mood % reporting improvement | 65% (128) | 90% (10) |
| Digestion % reporting improvement | 84% (111) | 0% (2) |
| Sleep % reporting improvement | 80% (76) | 100% (3) |
| Common side effects | fatigue, anhedonia, anxiety, headache | stomach issues, headache, stomach ulcers, liver toxicity |
| Typical dose reported | Not listed | Not listed |
BPC-157Full BPC-157 profile →
What a user said
“after 2+ years of nothing working, this is the 1st thing to reverse significant muscle damage ... 40% increase in my range of motion, and nearly the same in muscle strength.”
IbuprofenFull Ibuprofen profile →
Latest review conclusion
In this study, use of ibuprofen vs acetaminophen for the treatment of fever or pain in children younger than 2 years was associated with reduced temperature and less pain within the first 24 hours of treatment, with equivalent safety.
JAMA Netw Open, 2020 ↗What a user said
“I've always had a positive response to ibuprofen and would take it morning and night if it wasn't for the side effects and agmatine provides the same anti-depressant effects of ibuprofen.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate